Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval ...
The global schizophrenia drug market size was US$ 7.9 billion in 2021. The global schizophrenia drug market is forecast to grow to US$ 9.8 billion by 2030, registering a compound annual growth rate ...